Globally, primary dysmenorrhoea is one of the most frequent gynaecological disorders in young women. It is associated with increased uterine tone, and exaggerated contractility of uterine smooth muscles. In many rural African communities, a number of medicinal plants, including Psidium guajava Linn. (family: Myrtaceae), are used traditionally for the management, control and/or treatment of primary dysmenorrhoea. The present study was, therefore, undertaken to examine the spasmolytic effect of Psidium guajava leaf aqueous extract (PGE) on isolated, spontaneously-contracting and oestrogen-dominated, quiescent uterine horns of healthy, young adult, female Wistar rats. Graded, escalated concentrations of PGE (0.5-4.0 mg/ml) produced concentration-dependent and significant inhibitions of the amplitude of spontaneous phasic contractions of the isolated rat uterine horn preparations. In a concentration-related manner, PGE also significantly inhibited or abolished contractions produced by acetylcholine (ACh, 0.5-8.0 µg/ml), oxytocin (0.5-4.0 µU), bradykinin (2.5-10 ng/ml), carbachol (CCh, 0.5-8.0 µg/ml) or potassium chloride (K + , 10-80 mM) in quiescent uterine horn preparations isolated from the oestrogendominated rats. The spasmolytic effect of PGE observed in the present study lends pharmacological support to the traditional use of 'guava' leaves in the management, control and/or treatment of primary dysmenorrhoea in some rural African communities.
Introduction
Globally, primary dysmenorrhoea is one of the most common gynaecological disorders in young women (Doubova et al., 2007) . Women with primary dysmenorrhoea have been found to produce higher levels of prostaglandins (PGF2α) in their endometria, which in turn, increase uterine tones and cause exaggerated uterine muscle contractility (Speroff et al., 1999) . A Correspondence to: Prof. John A.O. Ojewole, Department of Pharmacology, School of Pharmacy and Pharmacology, Faculty of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa Phone: +27-31-260-7356/7767 Fax: +27-31-260-7907 e-mail: ojewolej@ukzn.ac.za number of medicinal plants, including Psidium guajava Linn. (family: Myrtaceae), is usually employed traditionally for the management, control and/or treatment of primary dysmenorrhoea in many rural African communities. At present, the Western, conventional treatment of primary dysmenorrhoea depends largely on the administration of non-steroidal anti-inflammatory drugs (NSAIDs) during the painful stages of the menstrual cycle (Doubova et al., 2007) . The use of infusions, decoctions and extracts of Psidium guajava leaves for the relief of some menstrual disorders associated with abdominal cramps and discomfort has been documented since ancient times (Conway, 2001) .
The oestrogenic property of flavonoids is well known. Flavonoids stimulate immature uterine muscles by acting on oestrogen receptors, thereby preventing binding of oestrogens to their receptors on uterine muscles (Revuelta et al., 1997) . The pharmacological effects of the flavonoid quercetin on β2-adrenoceptors have been described in intact rat adipocytes (Kuppusamy and Das, 1994) . The present study was, therefore, undertaken to investigate the effect of Psidium guajava leaf aqueous extract (PGE) on rat isolated uterine muscle contractility.
Materials and methods

Ethical considerations
Experimental protocols and procedures used in this study were approved by the Animal 
Preparation of Psidium guajava extract
One kilogramme of fresh Psidium guajava leaves was air-dried under shade for a period of 2 weeks at room temperature (26 ± 1°C). The dried leaves were milled into fine powder in a commercial Waring blender, macerated in distilled water for 48 hours (with occasional shaking) at room temperature (26 ± 1°C), and extracted twice, on each occasion with 2.5 l of distilled water. The combined aqueous extract solubles were filtered and concentrated under reduced pressure in a rotary evaporator at 60°C. Freeze-drying and solvent elimination of the resulting aqueous extract finally gave 36.56 g (i.e., 3.656% yield) of a light brown, powdery, crude Psidium guajava leaf aqueous extract (PGE). Without any further purification, aliquot portions of the plant's crude extract residue were weighed and dissolved in distilled water (at room temperature) for use on each day of our experiments.
Animals
Healthy, young adult, female Wistar rats (250-300 g) were used. The animals were kept and maintained under conventional laboratory conditions of temperature, humidity and light, and allowed free access to food (standard pellet diet) and drinking tap water ad libitum. All the animals were fasted for 16 h, but still allowed free access to drinking water, before the commencement of our experiments. The rats were euthanased by halothane inhalation. Euthanased rats were quickly placed on a dissecting table, and their abdomens were opened by midline incisions, following which the two uterine horns were quickly removed from the animals. The two uterine horn muscle segments were cleaned free from fat and connective tissues, and trimmed. In some of the experiments, the normal female rats used were pre-treated (i.e., primed) with stilboesterol (0.1 mg/kg subcutaneously) 20-24 hours prior to euthanasia and harvesting of uterine horns (in order to induce oestrous). Vaginal smears were taken immediately before sacrifice in order to ascertain that the animals were in oestrous.
Effect of PGE on rat isolated uterine horns
Each isolated uterine horn preparation was suspended under an applied resting tension of 1.0 g in a 30-ml Ugo Basile organ-bath containing De Jalon's physiological solution (DJS) of the following composition, in mM: NaCl, 154., KCl, 5.63., NaHCO3, 5.95., CaCl2, 0.65., and glucose, 2.77; pH adjusted to 7.4. The bathing DJS was maintained at 32 ± 1°C and continuously aerated with carbogen (i.e., 95% O2 + 5% CO2 gas mixture). The tubular uterine horn segments were kept in Ugo Basile organ-baths for 45-60 min, during which time the bathing DJS was changed every 15 min. After the equilibration period, the uterine horn preparations were challenged with graded concentrations of PGE (0.5-4.0 mg/ml), and/or reference drugs used, at different times. PGE and/or reference drug solutions used were added to the bath-fluid sequentially. Bathapplied PGE and/or reference drug concentrations used were repeated (where necessary) after washing out the previous PGE or reference drug concentrations 4-5 times, and subsequently allowing the tissues to rest for 5-10 min, or until its tone returned to baseline level. In order to make allowance for changes in tissue sensitivity, two isolated uterine horn preparations from the same animal were always set up at a time; one used as 'control' and the other one used as 'test' (i.e., PGE-or reference drug-treated) preparation. 'Control' uterine horn strips were only treated with distilled water equivalent to the volume/s (0.1-0.8 ml) of bath-applied PGE or reference drug/spasmogen solutions used. Each 'test' uterine horn preparation was used for one concentration-response curve only. Under the same experimental conditions, the possible role of β2-adrenoceptor stimulation in PGE-induced uterine muscle relaxation was examined by preincubating the uterine horn preparations with propranolol (10 -6 M) for 20 min before exposing the muscles to different concentrations of PGE.
In some experiments, agonist drug-and spasmogen-induced contractions of uterine horns isolated from stilboesterol-primed, oestrogen-dominated, non-pregnant rats were elicited by sequential, exogenous additions of either acetylcholine (ACh, 0.5-8.0 µg/ml), oxytocin (0.5-4.0 µU), bradykinin (2.5-10 ng/ml), carbachol (CCh, 0.5-8.0 µg/ml), or potassium chloride (K + , 10-80 mM) to the bath-fluid, followed, 30 sec later, by 4-5 times washouts. Maximal muscle tensions developed by the high concentrations of the agonist drug and spasmogens used were similar, and vary between 2.8 and 3.1 g. PGE-induced decreases in the agonist drug-or spasmogen-provoked muscle contractions were regarded as inhibitory effects of the plant's extract.
Drugs
The following reference drugs were used: acetylcholine chloride, carbachol chloride, potassium chloride (Sigma Chemical Co.), oxytocin (Parke-Davis), bradykinin (Sandoz), and stilboesterol (Kirby Pharmaceuticals). All drugs were dissolved and/or diluted in distilled water on each day of our experiments. Drug concentrations quoted in the text refer to final organ-bath concentrations.
Data analysis
Experimental data obtained are expressed as means (± standard errors of the means, SEM). Distilled water-induced 'control' means were used as baseline values. The differences in responses among the different groups were analysed for statistical significance by using OneSample Student's t-test, followed by Dunnett's post-hoc test. In all cases, values of P<0.05 were taken to imply statistical significance.
Results
Effect of PGE on rat isolated uterine horns
Isolated uterine horns harvested from normal (non-stilboesterol-primed) female rats exhibited spontaneous phasic contractions periodically, with a mean amplitude of 2.10 ± 0.3 g (n=8). PGE (0.5-4.0 mg/ml) raised the basal tone and reduced the amplitude of phasic contractions, in a concentration-dependent manner. Figure 1 shows a typical trace obtained with a uterine horn, while Fig. 2 summarizes the relaxant effects of PGE on uterine horn preparations. The IC50 value of the inhibitory effects of PGE was 0.45 ± 0.04 mg/ml (n=8). The inhibitory effects of PGE were reversed by washing out PGE for 4-5 times, and subsequently allowing the uterine tissue to rest for 5-10 min. Preincubation of the uterine strips with propranolol (10 -6 M) did not modify the relaxant effects of PGE (0.5-4.0 mg/ml) on the uterine horn preparations (data not shown).
Effects of PGE on spasmogen-induced contractions of uterine horns isolated from stilboesterolprimed, oestrogen-dominated, non-pregnant rats
Uterine horns taken from stilboesterol-primed, oestrogen-dominated, non-gregnant (normal) rats were always quiescent and devoid of spontaneous, rhythmic contractions. A range of PGE (0.5-4.0 mg/ml) inhibited or abolished contractions produced by acetylcholine (ACh), oxytocin, bradykinin, carbachol (CCh) or high-potassium solutions (K + , 10-80 mM), in a concentration-related manner, in the isolated, oestrogen-dominated, uterine horn muscles. 
Discussion
The findings of the present study indicate that Psidium guajava leaf aqueous extract (PGE, 0.5-4.0 mg/ml) inhibited or abolished the amplitude of spontaneous phasic contractions of uterine muscles, as well as the contractions elicited by agonists and spasmogens in oestrogendominated, quiescent uterine horn preparations. Phytochemical analysis of Psidium guajava leaf extract by a number of investigators (Vargas et al., 2006; Gutiérrez et al., 2008) have revealed the presence of flavonoids which include quercetin and its derivatives (guajaverin, isoquercitrin, hyperin, quercitrin, avicularin), morin and its derivatives (morin-3-O-α-Llixopyranoside and morin-3-O-α-L-arabopyranoside), rutin, myricetin, luteolin and kaempferol.
The flavonoids and terpenoids present in Psidium guajava leaf extract have been reported by some investigators to have antispasmodic effects on smooth muscle preparations, and to inhibit inflammation through prostaglandin-synthesis enzymatic system (Doubova et al., 2007) . In a study by Revuelta et al. (1997) , quercetin and kaemferol relaxed rat isolated uteri precontracted with potassium chloride. Thus, it is not unreasonable to speculate that quercetin, kaemferol and other flavonoids present in PGE might have contributed, at least in part, to the uterine relaxant effects observed in the present study. Uterine smooth muscle contraction is mediated mainly via increased intracellular Ca 2+ and is accomplished by excitation-contraction coupling mechanisms (Zhang et al., 2005) . A high K + medium could depolarize the cellular membrane of uterine smooth muscle (Bolton, 1979; Zhang et al., 2005) . Moreover, it is well-known that K + -induced contraction in smooth muscles is due to an increase in Ca 2+ influx through voltage-operated Ca 2+ channels (Kaya et al., 2002; Borrelli et al., 2006) . It has been suggested that any substance that inhibits high K + -induced contractions of smooth muscles is a blocker of Ca 2+ influx (Gilani et al., 2005) . It is also accepted that carbachol (CCh)-induced contractile responses following receptor activation require an increased intracellular Ca 2+ which is brought about by Ca 2+ influx through L-type Ca 2+ channels, and Ca 2+ release from intracellular calcium stores (Tanovic et al., 2000) . It has been reported that quercetin might be antagonizing the inward calcium membrane current, perhaps by blocking the L-type calcium membrane channels, leading to a decrease in smooth muscle contractile force (Lozoya et al., 1994) . However, in another study, it has been reported that quercetin is an activator of L-type calcium channels (Saponara et al., 2002) . These contradictory reports probably suggest that the spasmolytic activity of quercetin might be mediated via other mechanisms other than by antagonizing calcium membrane channels.
The finding that low to high concentrations of PGE inhibited or abolished contractions produced by ACh-, oxytocin-, bradykinin-, carbachol-and K + in oestrogen-dominated uterine horn preparations in a concentration-related manner, probably suggests that PGE-induced uterine horn relaxations are unlikely to be mediated through β2-adrenoceptor stimulation, and that the mechanisms involved in the inhibitory effects of PGE on rat isolated uteri are likely to be complex. The spasmolytic effect of PGE could, therefore, be mediated via a combination of several mechanisms, possibly including inhibition of (i) voltage dependent calcium (Ca 2+ ) channels, (ii) cyclic adenosine monophosphate (cAMP) dependent mechanisms, (iii) muscarinic cholinoceptorand/or oxytocin receptor-mediated mechanisms, and so forth. However, the failure of propranolol to modify uterine relaxant effect of PGE strongly suggests that PGE-induced uterine relaxation is probably not mediated via β2-adrenoceptor activation. In a study by Revuelta et al., (1997) , an inhibitor of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) and protein kinase C (PKC), N-p-tosyl-1-phenylalanine-chloromethyl-ketone (TPCK), significantly antagonised the uterine relaxation elicited by quercetin and kaemferol; thus suggesting that quercetin and kaempferol increase intracellular cAMP. The elevated intracellular cAMP would thus appear to contribute towards the relaxation of the uterus. The mechanism of cAMP increase in rat uterus by flavonoids could be brought about by inhibition of cAMP phosphodiesterase (Ferrell et al., 1979; Ortmann et al., 1979; Landolfi et al., 1984) . In addition, the possibility that PGE-or flavonoid-induced relaxations of the uterus might result from inhibition of protein kinases, such as myosin light chain kinase, and possibly other kinases involved in Ca
2+
-sensitizing mechanisms, including protein kinase C, still remains an attractive option. Taken together, however, the findings of the present study appear to suggest that the uterine relaxant effect of PGE is probably mediated through a non-specific, spasmolytic mechanism.
The combined anti-inflammatory and analgesic effects described earlier for this plant's extract (Gutiérrez et al., 2008) , and the antispasmodic effect of the plant's extract observed in the present study, support the clinical efficacy and use of Psidium guajava leaf in the treatment of dysmenorrhoea and other uterine spasmodic disorders. Based on our laboratory, experimental findings and the clinical observations of Doubova et al., (2007) , leaf extract of Psidium guajava could be recommended as a natural therapeutic alternative to non-steroidal anti-inflammatory drugs (NSAIDs) in the management, control and/or treatment of primary dysmenorrhoea.
